12-51116430-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2
The ENST00000257915.10(TFCP2):c.352-10A>T variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000799 in 1,499,466 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00093 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 14 hom. )
Consequence
TFCP2
ENST00000257915.10 splice_polypyrimidine_tract, intron
ENST00000257915.10 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.0009702
2
Clinical Significance
Conservation
PhyloP100: 1.35
Genes affected
TFCP2 (HGNC:11748): (transcription factor CP2) This gene encodes a transcription factor that binds the alpha-globin promoter and activates transcription of the alpha-globin gene. The encoded protein regulates erythroid gene expression, plays a role in the transcriptional switch of globin gene promoters, and it activates many other cellular and viral gene promoters. The gene product interacts with certain inflammatory response factors, and polymorphisms of this gene may be involved in the pathogenesis of Alzheimer's disease. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 12-51116430-T-A is Benign according to our data. Variant chr12-51116430-T-A is described in ClinVar as [Benign]. Clinvar id is 725865.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000933 (142/152182) while in subpopulation EAS AF= 0.0259 (134/5172). AF 95% confidence interval is 0.0223. There are 5 homozygotes in gnomad4. There are 75 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFCP2 | NM_005653.5 | c.352-10A>T | splice_polypyrimidine_tract_variant, intron_variant | ENST00000257915.10 | NP_005644.2 | |||
TFCP2 | NM_001173452.2 | c.352-10A>T | splice_polypyrimidine_tract_variant, intron_variant | NP_001166923.1 | ||||
TFCP2 | NM_001173453.2 | c.352-10A>T | splice_polypyrimidine_tract_variant, intron_variant | NP_001166924.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFCP2 | ENST00000257915.10 | c.352-10A>T | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_005653.5 | ENSP00000257915 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000947 AC: 144AN: 152064Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
144
AN:
152064
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00219 AC: 490AN: 223570Hom.: 14 AF XY: 0.00211 AC XY: 257AN XY: 121678
GnomAD3 exomes
AF:
AC:
490
AN:
223570
Hom.:
AF XY:
AC XY:
257
AN XY:
121678
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000784 AC: 1056AN: 1347284Hom.: 14 Cov.: 20 AF XY: 0.000804 AC XY: 539AN XY: 670358
GnomAD4 exome
AF:
AC:
1056
AN:
1347284
Hom.:
Cov.:
20
AF XY:
AC XY:
539
AN XY:
670358
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000933 AC: 142AN: 152182Hom.: 5 Cov.: 32 AF XY: 0.00101 AC XY: 75AN XY: 74408
GnomAD4 genome
AF:
AC:
142
AN:
152182
Hom.:
Cov.:
32
AF XY:
AC XY:
75
AN XY:
74408
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
22
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
TFCP2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 16, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 19, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at